Fund Holdings — Sanofi

Total Portfolio Value
$175.74M
Total Bought
$9.61M
Total Sold
$0
Net Transaction
+$9.61M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Omada Health Inc.(OMDA)0524,903+524,90309,6065.47%+9,606
AnaptysBio821,917821,917015,27918,24710.38%+2,967
Inozyme, Inc443,255443,25504031,7731.01%+1,370
Inhibrx Biosciences, Inc.(INBX)1,157,9261,157,926016,19916,5249.40%+324
LAVA Therapeutics N.V.1,919,4551,919,45502,4382,5341.44%+96
Q32 Bio Inc.(FIXX)244,083244,08304033640.21%-39
IGM Biosciences1,438,9751,438,97501,6551,6120.92%-43
Eledon(ELDN)814,980814,98002,7632,2091.26%-554
Novavax(NVAX)6,880,4816,880,481044,10443,34724.67%-757
MeiraGTx Holdings plc(MGTX)12,197,73712,197,737082,70179,52945.25%-3,171
Page 1 of 1
Sanofi — 13F Holdings — Q2 2025 | TickerTrail